Erratum to: The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women [Cancer Causes Control, DOI 10.1007/s10552-015-0542-3];The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women

Cancer Causes and Control

Volumn 26, Issue 5, 2015, Pages 713-719

  Benard, V B ^a   Royalty, J ^a   Saraiya, M ^a   Rockwell, T ^b   Helsel, W ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

Cervix neoplasms; Mass screening; Pap test

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; EARLY CANCER DIAGNOSIS; ETHNIC GROUP; FEMALE; HUMAN; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; POVERTY; PROCEDURES; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; YOUNG ADULT;

ADULT; AGED; EARLY DETECTION OF CANCER; ETHNIC GROUPS; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; POVERTY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84939939929     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0586-4     Document Type: Erratum

References (27)

1. Scarinci IC, Garcia FA, Kobetz E et al (2010) Cervical cancer prevention: new tools and old barriers. Cancer 116:2531–2542
2. Group UCSW (2013) United States cancer statistics: 1999–2010 incidence and mortality web-based report. In: Institute CfDCaPaNC (ed). U.S. Department of Health and Human Services, Atlanta
3. Leyden WA, Manos MM, Geiger AM et al (2005) Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 97:675–683
4. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA (2000) Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 88:2283–2289
5. Cancer screening-United States, 2010 (2012) MMWR. Morbidity and mortality weekly report. 61:41–45
6. Brown ML, Klabunde CN, Cronin KA, White MC, Richardson LC, McNeel TS (2014) Challenges in meeting healthy people 2020 objectives for cancer-related preventive services, National Health Interview Survey, 2008 and 2010. Prev Chron Dis 11:E29
7. Tangka F (2014). Cancer Causes Control
8. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 11:201–222
9. Watson M (2015). Cancer Causes and Control
10. Moyer VA (2012) Screening for cervical cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 156(880–91):W312
11. Saslow D, Solomon D, Lawson HW et al (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 137:516–542
12. USDA Rural–Urban Continuum Codes
13. Flagg EW, Datta SD, Saraiya M et al (2014) Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009. Cancer Causes Control 25:571–581
14. Schiffman M, Wentzensen N (2013) Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomark Prev 22:553–560
15. Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL (2012) The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 206(46):e1–e11
16. Bulletin AP (2003) Clinical management of guidelines for obstetrician–gynecologists. Number 45. Obstet Gynecol 102:417–427
17. Benard VB, Howe W, Saraiya M, Helsel W, Lawson HW (2008) Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000–2005. J Low Genit Tract Dis 12:300–306
18. Saslow D, Runowicz CD, Solomon D et al (2002) American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 52:342–362
19. Degroff A, Royalty JE, Howe W, Buckman DW, Gardner J, Poister T, Hayes N (2014) When performance management works: a study of the National Breast And Cervical Cancer Early Detection Program. Cancer 120(Suppl 16):2566–2574
20. Benard VB, Coughlin SS, Thompson T, Richardson LC (2007) Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstet Gynecol 110:681–686
21. Watson M, Saraiya M, Benard V et al (2008) Burden of cervical cancer in the United States, 1998–2003. Cancer 113:2855–2864
22. Chen HY, Kessler CL, Mori N, Chauhan SP (2012) Cervical cancer screening in the United States, 1993–2010: characteristics of women who are never screened. J Womens Health (Larchmt) 21:1132–1138
23. Stanley SL, Thomas CC, King JB, Richardson LC (2014) Predictors of never being screened for cervical cancer by metropolitan area. J Community Health 39:400–408
24. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP) MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control 56: 1–24
25. Murphy J, Kennedy EB, Dunn S et al. (2012) HPV testing in primary cervical screening: a systematic review and meta-analysis. Journal of obstetrics and gynaecology Canada: JOGC = Journal d’obstetrique et gynecologie du Canada: JOGC. 34: 443–52
26. Solomon D, Davey D, Kurman R et al (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114–2119
27. Massad LS, Einstein MH, Huh WK et al (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 121:829–846